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a b s t r a c t
It is important to determine the toxicity of compounds and co-solvents that are used in cell monolayer
permeability studies to increase conﬁdence in the results obtained from these in vitro experiments. This
study was designed to evaluate the cytotoxicity of new nifuroxazide derivatives with potential activity
against Methicillin-resistant Staphylococcus aureus (MRSA) in Caco-2 cells to select analogues for further
in vitro permeability analyses. In this study, nitrofurantoin and nifuroxazide, in addition to 6 furanic and 6
thiophenic nifuroxazide derivatives were tested at 2, 4, 6, 8 and 10 lg/mL. In vitro cytotoxicity assays
were performed according to the MTT (methyl tetrazolium) assay protocol described in ISO 10993-5.
The viability of treated Caco-2 cells was greater than 83% for all tested nitrofurantoin concentrations,
while those treated with nifuroxazide at 2, 4 and 6 lg/mL had viabilities greater than 70%. Treatment
with the nifuroxazide analogues resulted in viability values greater than 70% at 2 and 4 lg/mL with
the exception of the thiophenic methyl-substituted derivative, which resulted in cell viabilities below
70% at all tested concentrations. Caco-2 cells demonstrated reasonable viability for all nifuroxazide deriv-
atives, except the thiophenic methyl-substituted compound. The former were selected for further perme-
ability studies using Caco-2 cells.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the
major pathogens responsible for healthcare-associated infections
(HA-MRSA) and has also been identiﬁed in community-associated
infections (CA-MRSA). These bacteria have acquired multidrug
resistance to most major antimicrobial classes, including all beta
lactams, aminoglycosides, macrolides, ﬂuoroquinolones and tetra-
cyclines, in addition to glycopeptides, such as vancomycin and tei-
coplanin, which often represent a last resort for therapy (Jones,
2008). However, some vancomycin-resistant strains have recently
been described (Oliveira et al., 2001; Walsh and Amyes, 2004;
Finch and Hunter, 2006; Nordmann et al., 2007). 5-Nitro-heterocy-
clic compounds with structures similar to nifuroxazide, an antimi-
crobial agent used to treat gastrointestinal infections, have shown
satisfactory activity in vitro against multidrug-resistant strains of S.
aureus (Jorge et al., 2009; Masunari and Tavares, 2007). In the
course of the development of new drugs, evaluating the bioavail-
ability of lead compounds is necessary to select effective drugs
and further improve selected molecular structures.
Caco-2 cells, derived from a human colorectal carcinoma, are
the most frequently used of the many in vitro cell culture absorp-
tion models. These cells differentiate under culture conditions
while retaining most of the morphological and functional proper-
ties of human intestinal epithelial cells. Numerous studies have
demonstrated that the oral absorption of compounds in humans
correlated with their permeability through Caco-2 cells. Therefore,
a compound’s permeability through these cells is a valuable index
used to estimate the uptake of orally administered drugs (Balimane
et al., 2000; Gonçalves et al., 2009).
It is important to determine the toxicity of compounds and co-
solvents that are used in permeability studies through cell mono-
layers to increase conﬁdence in the results obtained from these
in vitro experiments, as high permeability values can result from
cell death and subsequent loss of monolayer function (Blanchﬁeld
et al., 2003). There are several standard methods to assess the tox-
icity of compounds against Caco-2 cells. These assays involve plac-
ing the substance in contact with the cultured cells and quantifying
the resulting cellular changes by different methods, including the
incorporation of vital dyes or the inhibition of cell colony
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formation (Rogero et al., 2000). The most common parameter used
to evaluate toxicity is cell viability, which can also be assessed by a
variety of assays. It is advisable to employee a technique that re-
quires less time and has minimal variation in sample analysis.
The MTT assay (3-(4,5-dimethylazol-2-yl)-2,5-diphenyl tetra-
zolium bromide) is used to quickly and objectively evaluate cell
viability based on a colorimetric reaction. In the mitochondria of
viable cells, succinate dehydrogenase converts MTT into formazan,
a dark blue product that is quantiﬁed by colorimetric measure-
ment following cell lysis. As damaged or dead cells exhibit reduced
levels of or no dehydrogenase activity, this colorimetric assay of
mitochondrial activity can be used to determine cell viability spec-
trophotometrically (Mosmann, 1983).
The mechanism of toxicity of nitro compounds is associated
with the formation of products resulting from the in vivo and
in vitro reduction of the nitro groups attached to aromatic rings
(Tocher, 1997). Xu et al. (2002) determined that the toxicity of this
class of compounds depends on their chemical stability, which is
related to the proportion and position of the nitro groups attached
to the aromatic rings and directly affects electron delocalization.
For example, oxygen is a reactive molecule that promotes the
breakdown of many aromatic compounds, which are further
metabolized through reactions that are catalyzed by mono- and
di-oxygenases (Spain, 1995). However, the strong electron with-
drawing character of the nitro groups in polynitroaromatic com-
pounds causes an electron deﬁciency in the aromatic ring, thus
favoring initial reduction reactions. The oxidative attack of nitroa-
romatic compounds occurs under aerobic conditions, while the
reductive metabolism of polynitroaromatic compounds can occur
both aerobically and anaerobically. Thus, the formation of hydroxyl
derivatives, which result from the oxidation of the aromatic ring by
mono- and di-oxygenases and subsequent ring opening, represents
the mechanistic explanation for the aerobic degradation of mono-
nitroaromatic compounds, and some di-nitroaromatic compounds
as well (Roldán et al., 1998; Spiess et al., 1998; Zablotowicz et al.,
1999; Nishino et al., 2000). Hydroxylamine derivatives that result
from the reduction of the nitro group may interact with biomole-
cules, such as DNA, to cause toxic and mutagenic effects. The toxic
effects are related to the electrophilic character of these deriva-
tives, while the mutagenic effects are mainly due to the formation
of hydroxylamine adducts resulting from esteriﬁcation with the
nucleic acid guanine. Additionally, some nitroaromatic compounds
are intrinsically toxic and function as uncouplers of oxidative phos-
phorylation, inhibiting the generation of the proton motive force
required for ATP synthesis (Roldán et al., 2008).
Currently, there is no data reported on the toxicity of the nitro
drugs nifuroxazide andnitrofurantoin in Caco-2 cells, the evaluation
of which is necessary prior to conducting permeability tests. This
study was designed to evaluate the cytotoxicity of these two drugs
and a series of nifuroxazide derivatives with potential activity
against MRSA in Caco-2 cells to select analogues for further perme-
ability analyses.
2. Material and methods
2.1. Chemicals
Dulbecco’s modiﬁed Eagle medium (DMEM) with and without
phenol, penicillin, streptomycin, trypsin–EDTA (0.2%) and fetal calf
serum (FCS) were obtained from Cultilab (Campinas, SP, Brazil).
Glutamine, D-glucose, 3-(4,5-dimethyl thiazolyl-2)-2,5-diphenyl-
tetrazolium bromide (MTT), nifuroxazide (Fig. 1A) and nitrofuran-
toin (Fig. 1B) were purchased from Sigma–Aldrich (St. Louis, MO,
USA).
The 5-nitro-heterocyclic compounds used in this study were de-
signed and synthesized by the Laboratory of Drug Design and
Development of the Chemical and Pharmaceutical Technology
Department at the Pharmaceutical Sciences Faculty/University of
São Paulo. Twelve compounds belonging to an analogous series
with structures similar to nifuroxazide were selected (Fig. 2).
2.2. Cell line and culture conditions
The Caco-2 human colon adenocarcinoma cell line (ATCC #HTB-
37) was purchased from American Type Culture Collection (ATCC,
Rockville, MD, USA). Caco-2 cells were cultured in DMEM supple-
mented with 4.5 g/L D-glucose (Sigma–Aldrich Corp., St. Louis,
MO), NaHCO3 (2.2 g/L) (Sigma–Aldrich Corp., St. Louis, MO), 10% fe-
tal bovine serum (Cultilab, Campinas, SP), 1% non-essential amino
acids (Sigma–Aldrich Corp., St. Louis, MO), 100 IU/mL penicillin
and 100 lg/mL streptomycin (Cultilab, Campinas, SP) in an atmo-
sphere of 5% CO2 and 90% relative humidity at 37 C. All cells used
in this study were between passages 40 and 50.
2.3. In vitro cytotoxicity
In vitro cytotoxicity assays were performed according to the
protocol described in the ISO 10993-5 guide (ISO, 2009). Brieﬂy,
Caco-2 cells were cultured in 96-well plates for 24 h at a seeding
density of 2  104 cells/well. 5-Nitro-heterocyclic compounds
were dissolved in dimethylsulfoxide (DMSO), a solvent frequently
used when poorly soluble compounds are evaluated in permeabil-
ity assays, and subsequently diluted in DMEM without phenol to
prepare samples of 2, 4, 6, 8 and 10 lg/mL concentration. Four rep-
licates of each concentration for all nitro compounds were assessed
in three independent assays for a total of 12 replicates. This range
of concentrations was chosen for reasons associated with subse-
quent permeability tests. First, this range was suggested by prior
knowledge related to the absorption of nitrofurantoin, a compound
structurally related to nifuroxazide and its derivatives. It is well
known that this compound is rapidly absorbed from the small
intestine, reaching high plasma concentrations in a few minutes
(Buzard et al., 1961). A high permeability rate through Caco-2 cell
membranes would be expected for analogous compounds as well,
so low initial concentrations would be preferred to avoid sink con-
ditions. Additionally, higher concentrations were prepared, but
precipitation was often observed due to the poor solubility of
nifuroxazide and its derivatives in Hanks buffer.
Samples containing 2% DMSO (v/v) in DMEM were employed to
assess the toxicity of this co-solvent (DMSO control). DMEM sam-
ples were used as negative controls, and 50% DMSO (v/v) in DMEM
as a positive control. The DMSO and positive controls were evalu-
ated in six replicates and negative controls were evaluated in 12
replicates for each 96-well plate. Experiments were initiated by
replacing the culture medium in each well with 100 lL of sample
or control solutions, followed by incubation for 4 h at 37 C in a
CO2 incubator. Then, solutions in each well were aspirated, and
the cells were incubated again for 2 h with 30 lL of MTT solution
(5 mg/mL, Sigma–Aldrich Corp., St. Louis, MO, in DMEM and PBS
buffer, 9:1 v/v). Next, formazan crystals were solubilized with
70 lL of isopropyl alcohol acidiﬁed with hydrochloric acid and
quantiﬁed spectrophotometrically at 570 and 690 nm (Spectra
Fluor plate reader, Tecan, Austria). Cell viability was calculated
based on the measured absorbance relative to the absorbance of
the cells exposed to the negative controls, which represented
100% cell viability.
2.4. Statistical analysis
All experiments were performed in 12 replicates (three inde-
pendent assays, each with four replicates). Data are expressed as
means ± standard deviations. Statistical analysis was performed
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using the Statistica statistical program (Statistica Software, Stat-
Soft, Oklahoma, USA). A t-test was used to compare nifuroxazide
to nitrofurantoin. A one way ANOVA test was applied for multiple
comparisons among the nitro compounds and the DMSO controls.
For both analyses, means were considered signiﬁcant if p < 0.05.
3. Results
The cytotoxicity of the 5-nitro-heterocyclic compounds in Caco-
2 cells in vitro are presented as a percentage of cell viability relative
to the negative (100%) and positive controls, as determined using
the MTT assay (Fig. 3). The standard deviation was calculated for
the 12 replicates of each concentration to determine the variation
in cytotoxicity for each compound (Fig. 3). Quantiﬁcation of cyto-
toxicity was determined by measuring cell death according to pro-
tocols described in ISO 10993-5 (ISO, 2009). This international
guide states that a reduction in cell viability by more than 30% is
considered a cytotoxic effect. For this reason, cell viabilities less
than 70% were used as cut-off values.
As shown in Fig. 3, nitrofurantoin was the least toxic substance
against Caco-2 cells, as demonstrated by greater than 83% cell via-
bility at all tested concentrations. For nifuroxazide, these values
were only greater than 70% at 2, 4 and 6 lg/mL, with the latter con-
centration corresponding to approximately 0.022 mM. A t-test
demonstrated apparent differences (p < 0.075) in the cytotoxicity
of these drugs at 6 and 8 lg/mL, and signiﬁcant differences at
10 lg/mL.
The acetyl-, ethoxy-, bromo- and amino-substituted thiophenic
compounds (AcTIO, EtoTIO, BrTIO and AminoTIO, respectively)
were shown to be the least toxic nifuroxazide derivatives, with cell
viabilities greater than 70% at all concentrations tested and BrTIO
being the least toxic of these compounds. The non-substituted
thiophenic derivative (HTIO) and the acetyl-, bromo- and amino-
substituted furanic derivatives (AcFUR, BrFUR and AminoFUR,
respectively) resulted in cell viabilities greater than 70% at 2, 4
and 6 lg/mL, while the non-substituted (HFUR), methyl- and eth-
oxy-substituted (MeFUR and EtoFUR) furanic derivatives resulted
in cell viabilities greater than 70% only at 2 and 4 lg/mL, with
the methyl derivative being the most toxic. The methyl-substituted
thiophenic derivative (MeTIO) reduced Caco-2 cell viability to less
than 70% at all tested concentrations. An ANOVA revealed that only
MeTIO had signiﬁcantly different results at all concentrations eval-
uated relative to the DMSO control.
4. Discussion
To avoid the loss of promising compounds due to insufﬁcient
intestinal absorption, adequate screening systems should be
implemented at early stages in the drug discovery process to assess
and/or predict the ability of a drug to be absorbed. The transport of
compounds through cell monolayers is a commonly used method
to assess the permeability potential of a compound during the
evaluation and selection stages of drug development. The viability
of Caco-2 cells treated with the compounds to be used in perme-
ability experiments is a pre-requisite to ensure reliable results.
As expected, signiﬁcant changes in cellular functions, especially
those related to cellular transport, are common in cells that have
initiated a cell death program. Additionally, the use of co-solvents
at high concentrations can affect the integrity of cell membranes.
Thus, it becomes essential to assess cell viability in the presence
of all substances and at all concentrations that are to be used in
permeability assays.
As the 5-nitro-heterocyclic compounds were dissolved in
DMSO, it was necessary to evaluate the toxicity of this co-solvent
on the cell monolayer at the experimental concentration (2% v/v).
The results demonstrated that cell viability for the DMSO control
was approximately 90%, which does not preclude its use in further
permeability assays at the tested concentration according to ISO
Fig. 1. (A) Molecular structure of nitrofurantoin. (B) Molecular structure of nifuroxazide.
aPurity values were calculated by using NMR and elemental analysis data.  
Substance Nickname A R Purity (%)a
5-nitro-2-furfurilydene benzydrazide HFUR O -H 97,05
5-nitro-2-furfurilydene 4-methylbenzydrazide MeFUR O -CH3 97,47
5-nitro-2-furfurilydene 4-etoxibenzydrazide EtoFUR O -OCH2CH3 99,93
5-nitro-2-furfurilydene 4-aminobenzydrazide AminoFUR O -NH2 99,85
5-nitro-2-furfurilydene 4-bromobenzydrazide BrFUR O -Br 99,77
5-nitro-2-furfurilydene 4-acetylbenzydrazide AcFUR O -COCH3 95,81
5-nitro-2-thiophilydene benzydrazide HTIO S -H 99,94
5-nitro-2-thiophilydene 4-methylbenzydrazide MeTIO S -CH3 96,86
5-nitro-2-thiophilydene 4-etoxibenzydrazide EtoTIO S -OCH2CH3 97,89
5-nitro-2-thiophilydene 4-aminobenzydrazide AminoTIO S -NH2 95,10
5-nitro-2-thiophilydene 4-bromobenzydrazide BrTIO S -Br 99,15
5-nitro-2-thiophilydene 4-acetylbenzydrazide AcTIO S -COCH3 95,41
Fig. 2. Chemical structure of the 5-nitro-heterocyclic derivatives used in this study and their purities.
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10993-5 (ISO, 2009). Furthermore, Da Violante et al. (2002) con-
cluded that DMSO may be used at concentrations up to 10% (v/v)
in permeability experiments using Caco-2 cells without any signif-
icant cell damage, which supports the results of the present study
and the use of this co-solvent in future permeation studies.
The results of the present study indicate that therewas no signif-
icant toxicity associated with nitrofurantoin and some nifuroxazide
derivatives, including AcTIO, EtoTIO, BrTIO and AminoTIO, at the
tested concentrations. However, signiﬁcant toxicity, as indicated
by cell viabilities less than 70%, was observed for nifuroxazide con-
centrations greater than 0.03 mM (8 lg/mL) following incubation
for 4 h. Blumenstiel et al. (1999), using nitrofuran derivatives with
activity against Trypanosoma cruzi, demonstrated that nifuroxazide
and nifuprazine had no toxic effects on mammalian cells (macro-
phages) following incubation for 3 days at concentrations lower
than 10 mM. In a cytotoxicity study conducted by Rossa et al.
(2003), thenitrofuranquinifuril showedhigh toxicity in rat leukemic
cells in vitro and low toxicity in non-tumor animal cells. Therefore, it
is plausible that the toxicity of nitro compounds is dependent on
multiple factors, including chemical structure, exposure time, dos-
age and the type of cell. Caco-2 cells were more susceptible to 5-ni-
tro-heterocyclic compounds than were macrophages (Blumenstiel
et al., 1999), probably because the former are derived from a carci-
noma, i.e., they are mammalian tumor cells. As these cytotoxic as-
says were performed prior to their cellular maturation into
epithelial cells, it is expected that these cellswould have greater via-
bilitywhen theyaredifferentiated.As treatmentwith themajorityof
the compounds, except for the MeTIO derivative, resulted in cell
viabilities greater than 70% at 2 and 4 lg/mL, the latter was selected
for further analysis of Caco-2 cell permeability.
Treatment with the methyl-substituted thiophenic derivative
(MeTIO) resulted in Caco-2 cell viabilities of less than 70% at all
tested concentrations; therefore, it was removed from the 5-ni-
tro-heterocyclic series of compounds that were further evaluated
for permeability. However, it is noteworthy that the methyl-substi-
tuted furanic derivative (MeFUR) was more toxic than the methyl-
substituted thiophenic derivative at 6, 8 and 10 lg/mL. With the
exception of these compounds, Caco-2 cell viability was greater
for cells treated with the thiophenic derivatives relative to their
respective furanic compounds. This result can be explained by
the higher atomic radius of the sulfur atom relative to the oxygen
atom. Consequently, the electrons in the valence shell of the for-
mer, which is the outermost layer of electrons and is responsible
for the atom’s reactivity, are spread over a larger space, resulting
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Fig. 3. Viability of Caco-2 cells incubated for 4 h with: (A) nifuroxazide and nitrofurantoin, (B) thiophenic derivatives and (C) furanic derivatives, all assessed by the MTT
technique. Each of the ﬁve concentrations was evaluated in 12 replicates for each compound. Error bars depict the primary results based on standard deviation. The red line
separates the cell viability values above and below 70%. Nitrofurantoin was the least toxic substance against Caco-2 cells. The methyl-substituted thiophenic derivative
(MeTIO) was the only substance which showed cell viability values less than 70% for all tested concentrations. NA t-test was used to compare nifuroxazide to nitrofurantoin;
⁄a one way ANOVA test was applied for multiple comparisons among the nitro compounds and the DMSO controls. For both analysis, means were considered signiﬁcant if
p < 0.05. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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in higher stability and lower reactivity than the oxygen atom. Thus,
the greater cytotoxicity of the furanic derivatives could be associ-
ated with the oxygen atom, which, due to its greater electron do-
nor characteristics, would increase the reactivity of the nitro
group attached to the furan ring. The differences in cytotoxicity be-
tween furanic and thiophene derivatives relative to their molecular
volume and surface charge can be explained based on differences
in their electrostatic and lipophilic properties, as illustrated in
Fig. 4. Fig. 4a depicts the electron density surface of BrTIO, the least
toxic compound of the series, and BrFUR, showing the greater ra-
dius of the sulfur atom and the higher electron density in the oxy-
gen atom. Fig. 4b illustrates the surface electrostatic potential of
BrTIO and BrFUR, which indicates that the most reactive portion
of the molecule is larger in the furanic derivatives compared to
the thiophene derivatives.
The toxicity of the MeTIO compound could be related to the in-
creased hydrophobicity that is conferred to the molecule by the
methyl group, as all other substituents are more hydrophilic in
character. Thus, the cytotoxicity of these nifuroxazide derivatives
could be inﬂuenced by both the reactivity of the ring atom linked
to the nitro group and the hydrophobicity of the substituent on
the benzene ring.
In addition to the cytotoxic evaluation of the substances that
will be used in further permeability assays, we performed an anal-
ysis of Caco-2 cell monolayer integrity. Transepithelial electrical
resistance (TEER) is extensively utilized as an indicator of cell via-
bility (Hidalgo, 1996), in combination with the use of model drugs,
i.e., compounds with known permeability values (FDA, 2000).
These latter two methods will be used in the further evaluation
of the nifuroxazide derivatives permeability. By comparing the re-
sults from these analyses with the cytotoxic data, we can increase
the conﬁdence in the permeability data obtained.
In addition to the use of Caco-2 cells as a screening tool for the
assessment of intestinal permeability, these cells have also been
used to predict the toxicity of new oral drug candidates and formu-
lation adjuvants in epithelial cells (Konsoula and Barile, 2005; Shah
et al., 2004; Rhoads et al., 2010). Consequently, we could conclude
that the MeTIO derivative is highly toxic to the intestinal epithe-
lium, which would invalidate its use as a drug. However, the AcTIO,
EtoTIO, BrTIO and AminoTIO derivatives displayed lower toxicity
than did nifuroxazide itself, which would make them potential
new drug candidates to be used in the treatment of MRSA strains.
Conﬂict of interest statement
There is no conﬂict of interest with any ﬁnancial organization
regarding the material discussed in the manuscript.
Acknowledgments
This work was supported by CNPq and FAPESP 2010/07188-7.
We thank Prof. Dr. Tânia Marcourakis and Msc. Raphael C. T. Garcia
from the Clinical and Toxicological Analysis Department of the
Pharmaceutical Sciences Faculty/USP for technical support.
References
Balimane, P.V., Chong, S., Morrison, R.A., 2000. Current methodologies used for
evaluation of intestinal permeability and absorption. J. Pharmacol. Toxicol. 44,
301–312.
Blanchﬁeld, J.T., Dutton, J.L., Hogg, R.C., Gallagher, O.P., Craik, D.J., Jones, A., Adams,
D.J., Lewis, R.J., Alewood, P.F., Toth, I., 2003. Synthesis, structure elucidation,
in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic
analogues of r-Conotoxin MII. J. Med. Chem. 46, 1266–1272.
Blumenstiel, K., Schöneck, R., Yardley, V., Croft, S.L., Krauft-Siegel, R.L., 1999.
Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi
lipoamide dehydrogenase and trypanothione reductase. Biochem. Pharmacol.
58, 1791–1799.
Buzard, J.A., Conklin, J.D., O’keefe, E., Paul, M.F., 1961. Studies on the absorption,
distribution and elimination of nitrofurantoin in the rat. J. Pharmacol. Exp. Ther.
131, 38–43.
Da Violante, G., Zerrouk, N., Richard, I., Provot, G., Chaumeil, J.C., Arnaud, P., 2002.
Evaluation of the cytotoxicity effect of dimethyl sulfoxide (DMSO) on Caco2/
TC7 colon tumor cell cultures. Biol. Pharm. Bull. 25, 1600–1603.
Food and Drug Administration. Guidance for Industry: Waiver of In Vivo
Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral
Dosage Forms based on Biopharmaceutics Classiﬁcation System. US
Department of Health and Human Services, Food and Drug Administration,
2000.
Finch, R., Hunter, P.A.J., 2006. Antibiotic resistance-action to promote new
technologies: report of an EU intergovernmental conference held in
Birmingham. J. Antimicrob. Chemother. 58, 159–167.
Gonçalves, J.E., Souza, J., Storpirtis, S., 2009. Avaliação da permeabilidade de
fármacos empregando culturas celulares, in: Storpirtis, S., GONÇALVES, J.E.,
Chiann, C., Gai, M.N. (Eds.), Biofarmacotécnica-Série Ciências Farmacêuticas,
Guanabara Koogan, Rio de Janeiro, pp. 204–211.
Hidalgo, I.H., 1996. Cultured intestinal epithelial cell models. In: Borchardt, T.,
Smith, P.L., Wilson, G. (Eds.), Models of Assessing Drug Absorption and
Metabolism. Plenum Press, New York, pp. 35–50.
ISO – International Organization for Standardization. ISO 10993-5 – Biological
Evaluation of Medical Devices. Part 5: Testes for in vitro cytotoxicity, 3ª Ed, ISO,
2009.
Jones, R.N., 2008. Key considerations in the treatment of complicated
staphylococcal infections. Clin. Microbiol. Infect. 14, 3–9.
Jorge, S.D., Masunari, A., Rangel-Yagui, C.O., Pasqualoto, K.F.M., Tavares, L.C., 2009.
Design, synthesis, antimicrobial activity and molecular modeling studies of
novel benzofuroxan derivatives against Staphylococcus aureus. Bioorgan. Med.
Chem. 17, 3028–3036.
Konsoula, R., Barile, F.A., 2005. Correlation of in vitro cytotoxicity with paracellular
permeability in Caco-2 cells. Toxicol. in Vitro 19, 675–684.
Masunari, A., Tavares, L.C., 2007. A new class of nifuroxazide analogues: synthesis of
5-nitrothiophene derivatives with antimicrobial activity against multidrug-
resistant Staphylococcus aureus. Bioorgan. Med. Chem. 15, 4229–4236.
Mosmann, T., 1983. Rapid colorimetric assay for cellular growth an survival
application to proliferation and cytotoxicity assays. J. Immunol. Methods 65,
55–63.
Fig. 4. (A) Electron density surface of BrTIO (above) and BrFUR (below). (B) Electrostatic potential surface of BrTIO (above) and BrFUR (below).
M.B. Fernandes et al. / Toxicology in Vitro 26 (2012) 535–540 539
Nishino, S.F., Paoli, G.C., Spain, J.C., 2000. Aerobic degradation of dinitrotoluenes and
pathway for bacterial degradation of 2,6-dinitrotoluene. Appl. Environ.
Microbiol. 66, 2139–2147.
Nordmann, P., Naas, T., Fortineau, N., Poirel, L., 2007. Superbugs in the coming new
decade: multidrug resistance and prospects for treatment of Staphylococcus
aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010. Curr. Opin.
Microbiol. 10, 436–440.
Oliveira, G.A., Della‘Aquila, A.M., Masiero, R.L., Levy, C.E., Gomes, M.S., Cui, L.,
Hiramatsu, K., Mamizuka, E.M., 2001. Isolation in Brazil of nosocomial
Staphylococcus aureus with reduced susceptibility to vancomicin. Infect. Contr.
Hosp. Epidem. 22 (7), 443–448.
Rhoads, L.S., Silkworth, W.T., Roppolo, M., Whittingham, M.S., 2010. Cytotoxicity of
nanostructured vanadium oxide on human cells in vitro. Toxicol. in Vitro 24,
292–296.
Rogero, S.O., Higa, O.Z., Saiki, M., Correa, O.V., Costa, I., 2000. Cytotoxicity due to
corrosion of ear piercing studs. Toxicol. in Vitro 14, 497–504.
Roldán, M.D., Blasco, R., Caballero, F.J., Castillo, F.J., 1998. Degradation of p-
nitrophenol by the phototrophic bacterium Rhodobacter capsulatus. Arch.
Microbiol. 169, 36–42.
Roldán, M.D., Pérez-Reinado, E., Castillo, F., Moreno-Vivína, C., 2008. Reduction of
polynitroaromatic compounds: the bacterial Nitroreductases. FEMS Microbiol.
Rev. 32, 474–500.
Rossa, M.M., Rocha-E-Silva, T.A.A., Terruggi, C.H.B., Tedesco, A.C., Selistre-De-Araujo,
H.S., Borissevich, I.E., Degterev, I.A., 2003. Comparison of the citotoxicity of two
nitroheterocyclic drugs (NHCD) towards transformed and non-transformed
cells. Pharmacol. Res. 48, 369–375.
Shah, R.B., Palamakula, A., Khan, M.A., 2004. Cytotoxicity evaluation of enzyme
inhibitors and absorption enhancers in Caco-2 Cells for oral delivery of salmon
calcitonin. J. Pharm. Sci. 93, 1070–1082.
Spain, J.C., 1995. Biodegradation of nitroaromatic compounds. Annu. Rev. Microbiol.
49, 523–555.
Spiess, T., Desire, F., Fischer, P., Spain, J.C., Knackmuss, H.-J., Lenke, H., 1998. A new
4-nitrotoluene degradation pathway in a Mycobacterium strain. Appl. Environ.
Microbiol. 64, 446–452.
Tocher, J.H., 1997. Reductive activation of nitroheterocyclic compounds. Gen.
Pharmacol. 28, 485–487.
Walsh, F.M., Amyes, S.G.B., 2004. Microbiology and drug resistance mechanisms of
fully resistant pathogens. Curr. Opin. Microbiol. 7, 439–444.
Xu, M., Zhang, A., Han, S., Wang, L., 2002. Studies of 3D-Quantitative Structure-
Activity Relationships on a set of nitroaromatic compounds: CoMFA advanced
CoMFA and CoMSIA. Chemosphere 48, 707–715.
Zablotowicz, R.M., Leung, K.T., Alber, T., Cassidy, M.B., Trevors, J.T., Lee, H., Veldhuis,
L., Hall, J.C., 1999. Degradation of 2,4-dinitrophenol and selected nitroaromatic
compounds by Sphingomonas sp. UG30. Can. J. Microbiol. 45, 840–848.
540 M.B. Fernandes et al. / Toxicology in Vitro 26 (2012) 535–540
